| [1] Andrews NC. Disorders of iron metabolism[J]. N Engl J Med,1999,341(26):1986-1995.[2] Wang Y,Wu M,Al-Rousan R,et al. Iron-induced cardiac damage:role of apoptosis and deferasirox intervention[J]. J Pharmacol Exp Ther,2011,336(1):56-63.[3] Fernandes JL,Sampaio EF,Fertrin K,et al. Amlodipine reduces cardiac iron overload in patients with thalassemia major:a pilot trial[J]. Am J Chin Med,2013,126(9):834-837.[4] Hentze MW,Muckenthaler MU,Galy B,et al. Two to tango:regulation of Mammalian iron metabolism[J]. Cell,2010,142(1):24-38.[5] Sripetchwandee J,KenKnight SB,Sanit J,et al. Blockade of mitochondrial calcium uniporter prevents cardiac mitochondrial dysfunction caused by iron overload[J]. Acta Physiol,2014,210(2):330-341.[6] Brown KE,Broadhurst KA,Mathahs MM,et al. Differential expression of stress-inducible proteins in chronic hepatic iron overload[J]. Toxicol Appl Pharmacol,2007,223(2):180-186.[7] Oudit GY,Trivieri MG,Khaper N,et al. Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy[J]. J Mol Med,2006,84(5):349-364.[8] Gao X,Campian JL,Qian M,et al. Mitochondrial DNA damage in iron overload[J]. J Biol Chem,2009,284(8):4767-4775.[9] Crist BL,Alekel DL,Ritland LM,et al. Association of oxidative stress,iron,and centralized fat mass in healthy postmenopausal women[J].J Womens Health,2009,18(6):795-801.[10] Sun L,Franco OH,Hu FB,et al. Ferritin concentrations,metabolic syndrome,and type 2 diabetes in middle-aged and elderly chinese[J]. J Clin Endocrinol Metab,2008,93(12):4690-4696.[11] Meli R,Mattace R,Irace C,et al.High fat diet induce sliver steatos is and early dysregulation of iron metabolismin rats[J].Plos One,2013,8(6):e66570.[12] Meerang M,Nair J,Sirankapracha P,et al. Accumulation of lipid peroxidation-derived DNA lesions in iron-overloaded thalassemic mouse livers:Comparison with levels in the lymphocytes of thalassemia patients[J]. Int J Cancer,2009,125(4):759-766.[13] Li H,Swiercz R,Englander EW. Elevated metals compromise repair of oxidative DNA damage via the base excision repair pathway:implications of pathologic iron overload in the brain on integrity of neuronal DNA[J]. J Neurochem,2009,110(6):1774-1783.[14] 王巍东,周陵菊. 血清铁蛋白与冠心病关系探讨[J]. 心脏杂志,2000,12(6):490-491.[15] Miskulin DC,Tangri N,Bandeen-Roche K,et al. Intravenous iron exposure and mortality in patients on hemodialysis[J]. Clin J Am Soc Nephrol,2014,9(11):1930-1939.[16] Zhang WJ,Wei H,Frei B. The iron chelator,desferrioxamine,reduces inflammation and atherosclerotic lesion development in experimental mice[J].Exp Biol Med,2010,235(5):633-641.[17] Haap M,Machann J,von Friedeburg C,et al. Insulin sensitivity and liver fat:role of iron load[J]. J Clin Endocrinol Metab,2011,96(6):E958-E961.[18] Kok BP,Brindley DN. Myocardial Fatty Acid metabolism and lipotoxicity in the setting of insulin resistance[J].Heart Fail Clin,2012,8(4):643-661.[19] Dongiovanni P,Fracanzani AL,Fargion S,et al. Iron in fatty liver and in the metabolic syndrome:a promising therapeutic target[J]. J Hepatol,2011,55(4):920-932.[20] Rajpathak SN,Crandall JP,Wylie-Rosett J,et al. The role of iron in type 2 diabetes in humans[J]. BBA Gen Subjects,2009,1790(7):671-681.[21] Murphy CJ,Oudit GY. Iron-overload cardiomyopathy:pathophysiology,diagnosis,and treatment[J]. J Card Fail,2010,16(11):888-900.[22] Corna G,Galy B,Hentze MW,et al. IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice[J]. J Mol Med,2006,84(7):551-560.[23] Rose RA,Sellan M,Simpson JA,et al. Iron overload decreases CaV1. 3-dependent L-type Ca2+ currents leading to bradycardia,altered electrical conduction,and atrial fibrillation[J].Circ Arrhythm Electrophysiol,2011,4(5):733-742.[24] Oudit GY,Trivieri MG,Khaper N,et al. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model[J]. Circulation,2004,109(15):1877-1885.[25] Klip IT,Comin-Colet J,Voors AA,et al. Iron deficiency in chronic heart failure:an international pooled analysis[J]. Am Heart J, 2013,165(4):575-582.[26] Oudit GY,Trivieri MG,Khaper N,et al. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model[J]. Circulation,2004,109(15):1877-1885.[27] Ozcan C,Palmeri M,Horvath TL,et al. Role of uncoupling protein 3 in ischemia-reperfusion injury,arrhythmias,and preconditioning[J]. Am J Physiol Heart Circ Physiol,2013,304(9):H1192-H1200.[28] Gao X,Qian M,Campian JL,et al. Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload[J]. Free Radic Biol Med,2010,49(3):401-407.[29] Cherednichenko G,Zima AV,Feng W,et al. NADH oxidase activity of rat cardiac sarcoplasmic reticulum regulates calcium-induced calcium release[J]. Circ Res,2004,94(4):478-486.[30] Goldhaber JI,Qayyum MS. Oxygen free radicals and excitation-contraction coupling[J]. Antioxid Redox Signal,2000,2(1):55-64.[31] Haøková P,Kovaøíková P,Koubková L,et al. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity[J]. Free Radic Biol Med,2011,50(4):537-549.[32] Thandavarayan RA,Watanabe K,Ma M,et al. Dominant-negative p38α mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus[J]. Am J Physiol Heart Circ Physiol,2009,297(3):H911-H919.[33] Schwartz KA,Li Z,Schwartz DE,et al. Earliest cardiac toxicity induced by iron overload selectively inhibits electrical conduction[J]. J Appl Physiol,2002,93(2):746-751.[34] Laurita KR,Chuck ET,Yang T,et al. Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy[J]. J Lab Clin Med,2003,142(2):83-89.[35] Tang WH,Wu S,Wong TM,et al. Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart[J]. Free Radic Biol Med,2008,45(5):602-610.[36] Meloni A,Luciani A,Positano V,et al. Single region of interest versus multislice T2MRI approach for the quantification of hepatic iron overload[J]. J Magn Reson Imaging,2011,33(2):348-355.[37] Wood JC. Cardiac iron across different transfusion-dependent diseases[J]. Blood Rev, 2008,22(Suppl 2):S14-S21.[38] Aessopos A,Kati M,Farmakis D. Heart disease in thalassemia intermedia:a review of the underlying pathophysiology[J]. Haematologica,2007,92(5):658-665.[39] Shaikh AY,Shih JA. Chemotherapy-induced cardiotoxicity[J]. Curr Oncol Rep,2012,9(2):117-127. |
